Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia

Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction

(2012) S. Mine et al.   BRITISH JOURNAL OF SURGERY

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Optimal Extent of Lymph Node Dissection for Siewert Type II Esophagogastric Junction Carcinoma

(2011) Hiroharu Yamashita et al.   ANNALS OF SURGERY

Clinicopathological Features and Prognostic Factors of Adenocarcinoma of the Esophagogastric Junction According to Siewert Classification: Experiences at a Single Institution in Japan

(2011) Yuichi Hosokawa et al.   ANNALS OF SURGICAL ONCOLOGY

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

(2011) Mitsuru Sasako et al.   JOURNAL OF CLINICAL ONCOLOGY

Functional outcomes after extended surgery for gastric cancer

(2010) Y. Kurokawa et al.   BRITISH JOURNAL OF SURGERY

Left thoracoabdominal esophagectomy: results from a single specialist center

(2010) R. S. Gillies et al.   DISEASES OF THE ESOPHAGUS

D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer

(2008) Mitsuru Sasako et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oxford experience with neoadjuvant chemotherapy and surgical resection for esophageal adenocarcinomas and squamous cell tumors

(2007) P. M. Safranek et al.   DISEASES OF THE ESOPHAGUS